Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

326.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.01m
  • Volume: 125,287
  • Market Cap: £326.55m
  • RiskGrade: 125

Small caps round-up: Sportech, Silverdell, Oxford BioMedica

Date: Friday 11 May 2012

LONDON (ShareCast) - Brooks Pierce, the Executive Director of Sportech, has resigned with immediate effect to 'pursue other business interests'. No replacement has yet been appointed, but the company was keen to announce that it had appointed an executive search business to 'seek suitable candidates to further augment Sportech's Executive Directors in order to take advantage of the many opportunities available in North America'.

Specialist environmental support services group Silverdell has been awarded a number of contracts in May totalling £3.58m, including a contract in Canada from an international specialist material company. The Canadian contract will deliver £1.25m of revenues in the second half of the current financial year and is an "important step" in the company's broader strategic initiative to penetrate a number of regulated international markets," the firm said. The company also reported that a previously announced rail contract worth £0.5m is likely to be materially higher in value and is now anticipated to form part of a larger framework contract to include up to 72 stations over the next seven years.

Oxford BioMedica has said it is very encouraged by the first clinical results of its RentinoStat product, which indicate sustained therapeutic protein expression in the eye. The company is now awaiting further data from its ocular programmes later this year. The firm has also been encouraged by progress at its proprietary manufacturing facility which is set to be fully-operational in the second half of this year, while developments by global drugs giant Pfizer with its 5T4-targeted antibody programme bring it a step closer to clinical trials, at which stage Pfizer would make its next milestone payment to Oxford BioMedica.

Braveheart Investment Group, which specialises in venture capital investments, has raised £164,000 after placing over one million new ordinary shares at 15p per share. The new subscription shares will represent around 4.8% of the issued share capital of the company as enlarged by the subscription. The proceeds of the subscription will be used for general working capital, the firm said.

Planet Payment has posted a 22% rise in net revenue to $11.7m (2011 $9.6m) for the first quarter, although income remained stable at $0.8m. Income from operations rose from $0.3m to $0.9m. The company said the growth in revenue reflects the increase in transaction processing volumes, primarily driven by increases in active merchant locations. Adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) for the period increased 75% to $1.7m (2011: $1.0m).

SnackTime, a UK vending business, has admitted that full-year EBITDA before exceptionals will be slightly below expectations, but said revenues will be on track and emphasised that the re-organisation of the company's property portfolio and associated provisions is expected to give rise to an exceptional profit. The firm's cash levels rose during the second half of the year and said that it remains well within its banking covenants. "SnackTime is well placed to weather the current economic conditions and to emerge from the recession in a stronger competitive position," the company said.

Educational software supplier RM has said that following a review of its UK operations it has decided to sell a number of its businesses, including ISIS Concepts, the sale of which has now been completed for £205,000. The sale was made to ISIS Concepts Holdings, a new company formed by Nick Topliss, who owned ISIS before it was sold to RM in 2009, and has remained as its Managing Director. Rob Sirs, former Managing Director of RM, is expected to invest in ISIS Concepts Holdings in the near future. In the financial year to date, ISIS has been loss-making. RM has agreed to provide a short-term working capital loan facility of up to £850,000, secured on freehold property and other assets valued in excess of that figure.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 326.50p
Change Today -2.50p
% Change -0.76 %
52 Week High 470.00
52 Week Low 166.80
Volume 125,287
Shares Issued 100.01m
Market Cap £326.55m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.06% below the market average28.06% below the market average28.06% below the market average28.06% below the market average28.06% below the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
Price Trend
5.23% below the market average5.23% below the market average5.23% below the market average5.23% below the market average5.23% below the market average
28.30% above the sector average28.30% above the sector average28.30% above the sector average28.30% above the sector average28.30% above the sector average
Income Not Available
Growth
52.82% below the market average52.82% below the market average52.82% below the market average52.82% below the market average52.82% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 10-Jun-2024

Time Volume / Share Price
16:35 12,641 @ 326.50p
16:35 393 @ 326.50p
16:35 181 @ 326.50p
16:35 163 @ 326.50p
16:35 69 @ 326.50p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page